Boston Scientific Corp. (BSX) — Analysis Summary
Boston Scientific Corp. (BSX) has a market cap of $71.81B with year-over-year revenue growth of +19.9%. Net margin stands at 14.4%. The stock trades at a P/E ratio of 20.2.
Key Takeaways
- Revenue changed +19.9% year-over-year
- Net margin of 14.4%
- P/E ratio of 20.2
Compared to other companies in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, BSX posted revenue growth of +19.9% and trades at a P/E of 20.2.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.